GUERINI ROCCO, ELENA
GUERINI ROCCO, ELENA
Dipartimento di Oncologia ed Emato-Oncologia
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
2024 E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco
Concurrent presence of primary hemangioma and breast cancer metastasis within a lymph node: a case report inspired by the legacy of Professor Juan Rosai
2024 M. Ivanova, M. D'Ercole, F.M. Porta, B. Di Venosa, C. Frascarelli, C. Di Bella, F. Pagni, E. Guerini-Rocco, N. Fusco
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype
2024 G. Corso, E. Marino, C. Zanzottera, C. Oliveira, L. Bernard, D. Macis, J. Figueiredo, J. Pereira, P. Carneiro, G. Massari, M. Barberis, A.M. De Scalzi, S.V. Taormina, E. Sajjadi, C. Sangalli, S. Gandini, O. D'Ecclesiis, C.M. Trovato, A. Rotili, F. Pesapane, L. Nicosia, C. La Vecchia, V. Galimberti, E. Guerini-Rocco, B. Bonanni, P. Veronesi
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a STRN-ALK fusion by artificial intelligence and molecular modelling: a case report
2024 M. Barberis, A. Rappa, F. de Marinis, G. Pelosi, E.G. Rocco, Y. Zhan, G. Tiana
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
2024 M. Ivanova, C. Frascarelli, B. Cerbelli, M.G. Pignataro, A. Pernazza, K. Venetis, E. Sajjadi, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, P. Graziano, M. Martini, G. D'Amati, N. Fusco
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment
2024 G. Corso, N. Fusco, E. Guerini-Rocco, M.C. Leonardi, C. Criscitiello, P. Zagami, E. Nicolo, G. Mazzarol, C. La Vecchia, F. Pesapane, C. Zanzottera, P. Tarantino, S. Petitto, B. Bianchi, G. Massari, A. Boato, A. Sibilio, A. Polizzi, G. Curigliano, A.M. De Scalzi, F. Lauria, B. Bonanni, M. Marabelli, A. Rotili, L. Nicosia, A. Albini, M. Calvello, R.A. Mukhtar, M.E. Robson, V. Sacchini, G. Rennert, V. Galimberti, P. Veronesi, F. Magnoni
Deep learning algorithm on H&E whole slide images to characterize TP53 alterations frequency and spatial distribution in breast cancer
2024 C. Frascarelli, K. Venetis, A. Marra, E. Mane, M. Ivanova, G. Cursano, F.M. Porta, A. Concardi, A.G.M. Ceol, A. Farina, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
2024 L. Antonio De Vitis, G. Schivardi, G. Caruso, C. Fumagalli, D. Vacirca, M. Teresa Achilarre, A. Aloisi, A. Garbi, V. Zanagnolo, G. Aletti, E. Guerini-Rocco, A. Mariani, A. Maggioni, M. Barberis, G. Bogani, N. Colombo, F. Multinu, I. Betella
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
2024 F. Pepe, K. Venetis, G. Cursano, C. Frascarelli, P. Pisapia, D. Vacirca, C. Scimone, A. Rappa, G. Russo, E. Mane, F. Pagni, I. Castellano, G. Troncone, C.D. Angelis, G. Curigliano, E. Guerini-Rocco, U. Malapelle, N. Fusco
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023 N. Fusco, M. Ivanova, C. Frascarelli, C. Criscitiello, B. Cerbelli, M. Gemma Pignataro, A. Pernazza, E. Sajjadi, K. Venetis, G. Cursano, F. Pagni, C. Di Bella, M. Accardo, M. Amato, P. Amico, C. Bartoli, G. Bogina, L. Bortesi, R. Boldorini, S. Bruno, D. Cabibi, P. Caruana, E. Dainese, E. De Camilli, V. Dell’Anna, L. Duda, C. Emmanuele, G. Nicolò Fanelli, B. Fernandes, G. Ferrara, L. Gnetti, A. Gurrera, G. Leone, R. Lucci, C. Mancini, G. Marangi, M.G. Mastropasqua, L. Nibid, S. Orrù, M. Pastena, M. Peresi, L. Perracchio, A. Santoro, V. Vezzosi, C. Zambelli, V. Zuccalà, A. Rizzo, L. Costarelli, F. Pietribiasi, A. Santinelli, C. Scatena, G. Curigliano, E. Guerini-Rocco, M. Martini, P. Graziano, I. Castellano, G. D'Amati
Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
2023 C. Pescia, E. Guerini-Rocco, G. Viale, N. Fusco
Trop-2 as an Actionable Biomarker in Breast Cancer
2023 G. Cursano, E. Frigo, E. Sajjadi, M. Ivanova, K. Venetis, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Pathology and Somatic Alterations in Hereditary Lobular Breast Cancers
2023 F.M. Porta, M.C. Blanco, M. Ivanova, N. Fusco, E. Guerini-Rocco
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking
2023 C. Frascarelli, G. Bonizzi, C. Rosella Musico, E. Mane, C. Cassi, E. GUERINI ROCCO, A. Farina, A. Scarpa, R. Lawlor, L. Reggiani Bonetti, S. Caramaschi, A. Eccher, S. Marletta, N. Fusco
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
2023 E. Sajjadi, E. Guerini-Rocco, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, M. Ivanova, N. Fusco
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
2023 F.M. Porta, E. Sajjadi, K. Venetis, C. Frascarelli, G. Cursano, E. Guerini-Rocco, N. Fusco, M. Ivanova